Maternal obesity and excess of fetal growth in pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 121, Issue 11, 2014, Pages 1351-1358

  Rasmussen, S ^a,b   Irgens, L M ^a   Espinoza, J ^c  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Birthweight; body mass index; large for gestational age; pre eclampsia

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL OBESITY; NORWAY; OBSERVATIONAL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; ADOLESCENT; COMPLICATION; FETAL MACROSOMIA; NEWBORN; OBESITY; PRE-ECLAMPSIA; PREGNANCY OUTCOME; PREVALENCE; RISK;

ADOLESCENT; ADULT; BIRTH WEIGHT; FEMALE; FETAL MACROSOMIA; HUMANS; INFANT, NEWBORN; NORWAY; OBESITY; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; RISK FACTORS;

EID: 84921819725     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12677     Document Type: Article

References (41)

1. Roberts JM, Hubel CA,. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30 (Suppl A): S32-7.
2. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-58.
3. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-83.
4. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005.
5. Chauhan SP, Scardo JA, Magann EF, Devoe LD, Hendrix NW, Martin JN Jr,. Detection of growth-restricted fetuses in preeclampsia: a case-control study. Obstet Gynecol 1999; 93: 687-91.
6. Haddad B, Kayem G, Deis S, Sibai BM,. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction? Am J Obstet Gynecol 2007; 196: e1-5.
7. Roberts DJ, Post MD,. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008; 61: 1254-60.
8. Belghiti J, Kayem G, Tsatsaris V, Goffinet F, Sibai BM, Haddad B,. Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol 2011; 205: e1-6.
9. Mirza FG, Strohsnitter WC, Rivera J, Gyamfi-Bannerman C,. Intrauterine growth restriction with abnormal umbilical artery Dopplers: a harbinger for preeclampsia? J Matern Fetal Neonatal Med 2012; 25: 2658-61.
10. Xiong X, Demianczuk NN, Buekens P, Saunders LD,. Association of preeclampsia with high birth weight for age. Am J Obstet Gynecol 2000; 183: 148-55.
11. Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD,. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 2002; 155: 203-9.
12. Rasmussen S, Irgens LM,. Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003; 101: 575-83.
13. Irgens LM,. Commentary: on the clinical prediction of pre-eclampsia and its enigmatic aetiology. Int J Epidemiol 2007; 36: 420-1.
14. Roberts JM, Catov JM,. Preeclampsia more than 1 disease: or is it? Hypertension 2008; 51: 989-90.
15. Hoegsberg B, Gruppuso PA, Coustan DR,. Hyperinsulinemia in macrosomic infants of nondiabetic mothers. Diabetes Care 1993; 16: 32-6.
16. Yu CK, Teoh TG, Robinson S,. Obesity in pregnancy. BJOG 2006; 113: 1117-25.
17. Espinoza J, Uckele JE, Starr RA, Seubert DE, Espinoza AF, Berry SM,. Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 2010; 203: e1-8.
18. Espinoza J,. Uteroplacental ischemia in early- and late-onset pre-eclampsia: a role for the fetus? Ultrasound Obstet Gynecol 2012; 40: 373-82.
19. Irgens LM,. The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000; 79: 435-9.
20. World Health Organization. Global Database on Body Mass Index. Geneva: World Health Organization, 2013. [ http://apps.who.int/bmi/ ]. Accessed 9 November 2013.
21. Gifford RW, August PA, Cunningham G, Green LA, Lindheimer MD, McNellis D, et al. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-22.
22. Gissler M, Louhiala P, Hemminki E,. Nordic Medical Birth Registers in epidemiological research. Eur J Epidemiol 1997; 13: 169-75.
23. Engeland A, Bjørge T, Daltveit AK, Vollset SE, Furu K,. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2009; 88: 1083-9.
24. Thomsen LC, Klungsøyr K, Roten LT, Tappert C, Araya E, Bærheim G, et al. Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2013; 92: 943-50.
25. Vangen S, Stoltenberg C, Holan S, Moe N, Magnus P, Harris JR, et al. Outcome of pregnancy among immigrant women with diabetes. Diabetes Care 2003; 26: 327-32.
26. Chen XK, Wen SW, Smith GN, Yang Q, Walker MC,. New-onset hypertension in late pregnancy and fetal growth: different associations between singletons and twins. Hypertens Pregnancy 2007; 26: 259-72.
27. Powe CE, Ecker J, Rana S, Wang A, Ankers E, Ye J, et al. Preeclampsia and the risk of large-for-gestational-age infants. Am J Obstet Gynecol 2011; 204: e1-6.
28. Brazy JE, Grimm JK, Little VA,. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr 1982; 100: 265-71.
29. Moore MP, Redman CW,. Case-control study of severe pre-eclampsia of early onset. Br Med J (Clin Res Ed) 1983; 287: 580-3.
30. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD,. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006; 113: 580-9.
31. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP,. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294: H541-50.
32. Gant NF, Hutchinson HT, Siiteri PK, MacDonald PC,. Study of the metabolic clearance rate of dehydroisoandrosterone sulfate in pregnancy. Am J Obstet Gynecol 1971; 111: 555-63.
33. Easterling TR, Benedetti TJ, Schmucker BC, Millard SP,. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990; 76: 1061-9.
34. Zavalza-Gomez AB,. Obesity and oxidative stress: a direct link to preeclampsia? Arch Gynecol Obstet 2011; 283: 415-22.
35. Bodnar LM, Ness RB, Harger GF, Roberts JM,. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005; 162: 1198-206.
36. Sohlberg S, Stephansson O, Cnattingius S, Wikstrom AK,. Maternal body mass index, height, and risks of preeclampsia. Am J Hypertens 2012; 25: 120-5.
37. Djelantik AA, Kunst AE, van der Wal MF, Smit HA, Vrijkotte TG,. Contribution of overweight and obesity to the occurrence of adverse pregnancy outcomes in a multi-ethnic cohort: population attributive fractions for Amsterdam. BJOG 2012; 119: 283-90.
38. Freeman DJ,. Effects of maternal obesity on fetal growth and body composition: implications for programming and future health. Semin Fetal Neonatal Med 2010; 15: 113-18.
39. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175-82.
40. Schaefer-Graf UM, Heuer R, Kilavuz O, Pandura A, Henrich W, Vetter K,. Maternal obesity not maternal glucose values correlates best with high rates of fetal macrosomia in pregnancies complicated by gestational diabetes. J Perinat Med 2002; 30: 313-21.
41. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, Dudenhausen J, Vetter K, et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008; 31: 1858-63.